JPS5861465A - Analytical method for blood - Google Patents

Analytical method for blood

Info

Publication number
JPS5861465A
JPS5861465A JP15971481A JP15971481A JPS5861465A JP S5861465 A JPS5861465 A JP S5861465A JP 15971481 A JP15971481 A JP 15971481A JP 15971481 A JP15971481 A JP 15971481A JP S5861465 A JPS5861465 A JP S5861465A
Authority
JP
Japan
Prior art keywords
hemolysis
blood
reagent
layer
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15971481A
Other languages
Japanese (ja)
Inventor
Hideki Jinno
英毅 神野
Toshiaki Tsutsui
筒井 聰明
Kazutoshi Shimamoto
嶋本 三利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
YATORON KK
Mitsubishi Kasei Corp
Mitsubishi Kagaku Iatron Inc
Original Assignee
YATORON KK
Mitsubishi Kasei Corp
Mitsubishi Kagaku Iatron Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by YATORON KK, Mitsubishi Kasei Corp, Mitsubishi Kagaku Iatron Inc filed Critical YATORON KK
Priority to JP15971481A priority Critical patent/JPS5861465A/en
Publication of JPS5861465A publication Critical patent/JPS5861465A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • G01N33/723Glycosylated haemoglobin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PURPOSE:To permit extremely easy measurement of glycosyl hemoglobin, etc. in blood by adding a hemolysis medium prepd. by adsorbing a reagent for hemolysis on a porous material on the sample supply side of a separating medium layer or a reagent layer for inspection of blood of a chromatography or the like. CONSTITUTION:A vinyl resin molding, an inorg. porous plate, etc. having holes of about 1- several mu sizes are used for a porous material to be adsorbed thereon with a reagent for hemolysis. Noionic or ionic surfactants are usable as the reagent for hemolysis, of which polyoxyethylene alkyl allyl ether, salt of sulfuric ester of higher fatty acid, etc. are more perferable in terms of hemolysis characteristic. In this invention, the hemolysis medium is added on the sample supply side of a separating medium layer or a reagent layer for inspection of blood; therefore, the blood analysis by using all the blood samples as they are is made possible without preparing hemolysis samples separately and this method is suitable for analysis of many specimens at one time.

Description

【発明の詳細な説明】 本発明は、例えばグリコジルヘモグロビン等の測定に好
適な血液の分析方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a blood analysis method suitable for measuring glycosylated hemoglobin and the like.

最近、臨床検査法の発展につれて、多数性の生体成分の
分析を迅速に行う必要性が生じて来た。特に゛血球中の
成分の検索を行う場合、血球を破壊して内容物を得るた
め簡便にかつすみやかに溶血液を得ることが必要でbる
Recently, with the development of clinical testing methods, there has been a need to rapidly analyze a large number of biological components. Particularly when searching for components in blood cells, it is necessary to easily and quickly obtain hemolysis in order to destroy the blood cells and obtain the contents.

しかしながら、溶血用試薬と血液を混合し攪拌すること
により溶血液を得る通常の溶血方法は、血球の溶血と血
液分析の操作を2段階で別個に行わなければならないた
め煩雑であり、また血液を直接取扱うため感染の問題も
あって、臨床検査等で一時に多数検体を溶血処理するた
めには満足すべきものではない。
However, the usual hemolysis method, in which hemolysis is obtained by mixing and stirring a hemolysis reagent and blood, is complicated because hemolysis of blood cells and blood analysis must be performed in two separate steps. Since it is handled directly, there is a problem of infection, and it is not satisfactory for hemolyzing a large number of specimens at once in clinical tests, etc.

本発明者らは、この点を改良すべく、種々の検討を行な
い、溶血試料の分析に好適な方法を見出し、本発明に到
達した。
In order to improve this point, the present inventors conducted various studies, found a method suitable for analyzing hemolyzed samples, and arrived at the present invention.

/′ すな句・、ち、本発明は多孔質材料に溶血用試薬を吸着
握せた溶血媒体を、り・−トゲラフイー等の分離媒体層
、又は血液検査試薬層の試料供給側に添加することを特
徴とする血液の分析方法にある。
/' In other words, the present invention adds a hemolytic medium in which a hemolytic reagent is adsorbed to a porous material to a separation medium layer such as li-togelafy or to the sample supply side of a blood test reagent layer. A blood analysis method is characterized by the following.

以下、本発明を説明する。The present invention will be explained below.

まず、本発明における溶血媒体は、多孔質材料に溶血用
試薬を吸着させてなる。上記多孔質材料としては、径l
〜数μ程度の孔を有する材料、例えば、酢酸ビニル樹脂
等のビニル系樹脂成形体無機質多孔板等が用いられる。
First, the hemolysis medium in the present invention is made by adsorbing a hemolysis reagent onto a porous material. The porous material has a diameter l
A material having pores of approximately several microns is used, for example, a molded inorganic porous plate of vinyl resin such as vinyl acetate resin.

上記溶血媒体の形状は、球状、板状等、特に制限されず
、大きさも特に制限されないflf#。
The shape of the hemolysis medium is not particularly limited, such as spherical or plate-like, and the size is also not particularly limited.

通常、溶血用試薬を5〜t 00 pf程度吸着できる
容量を有するものが選ばれる。
Usually, a material having a capacity capable of adsorbing a hemolysis reagent of about 5 to t 00 pf is selected.

この多孔質材料に吸着させる溶血用試薬としては、非イ
オン系又はイオン系界面活性剤が挙げられる。例えば、
非イオン系界面活性剤としては、ポリオキシエチレンア
ルキルエーテル。
Examples of the hemolysis reagent to be adsorbed onto this porous material include nonionic or ionic surfactants. for example,
Polyoxyethylene alkyl ether is a nonionic surfactant.

ポリオキシエチレンソルビタン脂肪酸エステル、脂肪酸
グリセライド、ポリオキシエチレン脂肪酸エステル、ポ
リオキシエチレン了りルエーテル、ソルビタン脂肪酸エ
ステル、しよ糖脂肪酸エステル、ホリオキシエチレンア
ルキルアミン等が挙げられ、イオン系界面活性剤として
は高級脂肪酸硫酸エステル塩、高級アルコール硫酸エス
テル塩等が挙げられるが、溶血性の点で、ホリオキシエ
チレンアルキルアリルエーテル、高級脂肪酸硫酸エステ
ル塩等が好ましい。
Examples of ionic surfactants include polyoxyethylene sorbitan fatty acid ester, fatty acid glyceride, polyoxyethylene fatty acid ester, polyoxyethylene ester, sorbitan fatty acid ester, sucrose fatty acid ester, and phoroxyethylene alkylamine. Examples include higher fatty acid sulfate ester salts, higher alcohol sulfate ester salts, etc., but phoroxyethylene alkyl allyl ether, higher fatty acid sulfate ester salts, etc. are preferred from the viewpoint of hemolytic properties.

本発明における溶血媒体は、これらの溶血用試薬を水溶
媒又はアルコール系等の有機溶媒に溶解し、通常l〜i
ooμt/me程度、好ましくは10−20μf/ld
の溶液とし、これに上記多孔質材料を通常、室温程度の
温度で数秒〜数分程度含浸させ、次いで風乾もしくはl
IO〜ioo℃程度の温度で加熱乾燥させて溶媒を除去
することにより得られる。
The hemolytic medium in the present invention is prepared by dissolving these hemolytic reagents in an aqueous solvent or an organic solvent such as an alcoholic solvent, and usually contains l to i
About ooμt/me, preferably 10-20μf/ld
The porous material is usually impregnated with this solution for several seconds to several minutes at a temperature around room temperature, and then air-dried or
It is obtained by removing the solvent by heating and drying at a temperature of about IO to ioo°C.

一方、血液成分の分離媒体層としては、アルミナゲル、
セルロースゲル、でんぷんゲル、イオン交換樹脂等の、
通常、カラムクロマトグラフィー、液体クロマトグラフ
ィー用充填剤として用いられるものからなるものが挙げ
られる。
On the other hand, as a separation medium layer for blood components, alumina gel,
Cellulose gel, starch gel, ion exchange resin, etc.
Examples include those normally used as packing materials for column chromatography and liquid chromatography.

また、血液検査試薬層としては、ヘモグロビンの定量試
薬、血球内成分である。A T P (’adenin
etriphosphate )、2.3− DPG 
(,2,、? −diphospho−glycera
tθ)等を測定する酵素試薬等、を緩衝液中に溶解した
ものからなるものが挙げられる。。
Further, the blood test reagent layer is a quantitative reagent for hemoglobin and intrablood cell components. A T P ('adenin
etriphosphate), 2.3-DPG
(,2,,? -diphospho-glycera
Examples include those made of an enzyme reagent for measuring tθ) etc. dissolved in a buffer solution. .

ば、ガラスまたはプラスチック製のカラム中に分離媒体
を充填し、この分離媒体゛層上部(試料供給側に)溶出
に用いる緩衝液をおよそ1Otanの高さ加えてその液
中に溶血媒体を加える。次に分析に供する血液ioμt
を加えて卓上ミキサー等でカラムととO,S〜1.0秒
攪拌するとカムム中分離媒体上で溶血液ができ、これを
溶出させることにより、ただちに血液のカラム分析がで
きる。
For example, a glass or plastic column is filled with a separation medium, a buffer solution used for elution is added to the upper part of the separation medium layer (on the sample supply side) to a height of approximately 1000 ml, and a hemolytic medium is added to the column. Blood ioμt to be analyzed next
When added to the column and stirred with a tabletop mixer etc. for ~1.0 seconds, hemolysate is formed on the separation medium in the Camum, and by eluting this, blood can be immediately analyzed in the column.

この場合、溶血媒体より溶離した溶血試薬が分離媒体層
又は血液検査試薬層に流出するが。
In this case, the hemolytic reagent eluted from the hemolytic medium flows into the separation medium layer or the blood test reagent layer.

ごく低濃度であるので分析に支障をきたすものではない
Since the concentration is extremely low, it does not interfere with analysis.

本発明の血液の分析方法は、例えば、糖代謝異常を量的
にみるため、クロマトグラフィー法ニヨルクリコシルヘ
モグロビン(g17CO871atedhemoglo
bin)を測定する場合等に好適に使用される。
In the blood analysis method of the present invention, for example, in order to quantitatively examine abnormalities in glucose metabolism, chromatography method is used.
It is suitably used when measuring (bin).

この場合、分離媒体層としては、弱酸性カチオン交換樹
脂が使用される。例えばメタクリル酸、アクリル酸など
の不飽和カルボン酸をジビニルベンゼン、ジビニルトル
エン等の架橋剤で架橋させた重合体等が挙げられる。
In this case, a weakly acidic cation exchange resin is used as the separation medium layer. Examples include polymers obtained by crosslinking unsaturated carboxylic acids such as methacrylic acid and acrylic acid with crosslinking agents such as divinylbenzene and divinyltoluene.

本発明の血液の分析方法は、別途溶血試料を調製するこ
となく、全血試料をそのまま用いて血液分析することが
できるので、一時に多数検体の分析を行うのに好適であ
るとともに血液を直接操作しなくて済むため、肝炎ウィ
ルス等の感染等も防げる利点がある。
The blood analysis method of the present invention allows blood analysis to be performed using a whole blood sample as it is without separately preparing a hemolyzed sample, so it is suitable for analyzing a large number of samples at once, and it is also suitable for analyzing blood directly. Since no operation is required, it has the advantage of preventing infections such as hepatitis viruses.

以下、実施例により、本発明をさらに詳細に説明するが
、本発明はその要旨を超えない限り、この実施例に限定
されるものではない。
EXAMPLES Hereinafter, the present invention will be explained in more detail with reference to Examples, but the present invention is not limited to these Examples unless the gist thereof is exceeded.

実施例1 酢酸ビニル樹脂製多孔質材料(φ= g mm、厚さ2
 m )を界面活性剤水溶液lθμl/d (ロームア
ンドハース社製triton / 00 t )中に浸
漬した後、SO℃で3時間air bath中で乾燥さ
せる。
Example 1 Porous material made of vinyl acetate resin (φ = g mm, thickness 2
m) in an aqueous surfactant solution lθμl/d (triton/00t manufactured by Rohm and Haas), and then dried in an air bath at SO°C for 3 hours.

グリコシルヘ−モグロビンを測定するために、分離媒体
として弱酸性イオン交換樹脂を充填したプラスチック製
カラム(g=/crn、高さ1lcrn)、に50θμ
tのグリコジルヘモグロビン溶出用緩衝液を添加する。
To measure glycosyl hemoglobin, a plastic column (g=/crn, height 1 lcrn) packed with a weakly acidic ion exchange resin as a separation medium was charged with 50 θμ.
Add t glycosylated hemoglobin elution buffer.

次に多孔質で球状又は円板状の溶血媒体を各カラムに加
え、更にトリペット等で秤量した/ Opiの全血試料
をこの系に加えカラムを軽くふるか、卓上ミキサー等で
0.5〜/、0秒間攪拌すると、血球は溶血し、カラム
の出 願 人  三菱化成工業株式会社 ほか1名 代 理 人  弁理士 長谷用  − ほか1名
Next, a porous, spherical or disc-shaped hemolysis medium was added to each column, and a weighed/Opi whole blood sample was added to the system, and the column was gently shaken, or 0.5 ~/, When stirred for 0 seconds, the blood cells become hemolyzed, and the applicant for the column: Mitsubishi Chemical Industries, Ltd. and 1 other representative Patent attorney Hase - 1 other person

Claims (1)

【特許請求の範囲】[Claims] (1)血液成分の分離媒体層又は血液検査試薬層を有す
る血液分析用カラムを用いる血液の分析方法において、
多孔質材料に溶血用試薬を吸着させた溶血媒体を、該分
離媒体層又は血液検査試薬層の試料供給側に添加するこ
とを特徴とする血液の分析方法。
(1) In a blood analysis method using a blood analysis column having a blood component separation medium layer or a blood test reagent layer,
A method for analyzing blood, which comprises adding a hemolysis medium in which a hemolysis reagent is adsorbed to a porous material to the sample supply side of the separation medium layer or the blood test reagent layer.
JP15971481A 1981-10-07 1981-10-07 Analytical method for blood Pending JPS5861465A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15971481A JPS5861465A (en) 1981-10-07 1981-10-07 Analytical method for blood

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15971481A JPS5861465A (en) 1981-10-07 1981-10-07 Analytical method for blood

Publications (1)

Publication Number Publication Date
JPS5861465A true JPS5861465A (en) 1983-04-12

Family

ID=15699676

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15971481A Pending JPS5861465A (en) 1981-10-07 1981-10-07 Analytical method for blood

Country Status (1)

Country Link
JP (1) JPS5861465A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215401A2 (en) * 1985-09-14 1987-03-25 Roche Diagnostics GmbH Method and composition for determining glycosylated hemoglobin as well as compounds suited therefor and methods for their preparation
JPH01191057A (en) * 1988-01-27 1989-08-01 Toa Medical Electronics Co Ltd Reagent and method for measuring white cell and hemoglobin in blood
EP0559164A2 (en) * 1992-03-05 1993-09-08 Roche Diagnostics GmbH Immunological method to determine HbAIc
WO2004106930A1 (en) * 2003-05-27 2004-12-09 Mitsubishi Kagaku Iatron, Inc. Immunochromatographic method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243534A (en) * 1979-01-25 1981-01-06 Becton, Dickinson And Company Blood separation
JPS561430A (en) * 1979-06-20 1981-01-09 Hitachi Ltd Breaker

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4243534A (en) * 1979-01-25 1981-01-06 Becton, Dickinson And Company Blood separation
JPS561430A (en) * 1979-06-20 1981-01-09 Hitachi Ltd Breaker

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215401A2 (en) * 1985-09-14 1987-03-25 Roche Diagnostics GmbH Method and composition for determining glycosylated hemoglobin as well as compounds suited therefor and methods for their preparation
JPH01191057A (en) * 1988-01-27 1989-08-01 Toa Medical Electronics Co Ltd Reagent and method for measuring white cell and hemoglobin in blood
EP0559164A2 (en) * 1992-03-05 1993-09-08 Roche Diagnostics GmbH Immunological method to determine HbAIc
JPH0611510A (en) * 1992-03-05 1994-01-21 Boehringer Mannheim Gmbh Immunological method for measuring hemoglobin derrivative
WO2004106930A1 (en) * 2003-05-27 2004-12-09 Mitsubishi Kagaku Iatron, Inc. Immunochromatographic method

Similar Documents

Publication Publication Date Title
JP6387072B2 (en) Immunoassay kit and analytical method using the same
AU682999B2 (en) Process for stabilizing the content of glycated protein of a sample on a matrix material
US3733179A (en) Method and apparatus for the quantitative determination of blood chemicals in blood derivatives
JP2000329761A (en) Porous reagent discharging system and its manufacture
US4409335A (en) Method for eliminating glucose dependent Schiff base effect from hemoglobin A1 assay
EP0746767B1 (en) Analyzer cuvette, method and diagnostic test kit for determination of analytes in whole blood samples
CA2828162C (en) Solid support and method of recovering biological material therefrom
JPH05133938A (en) Method for separating glycosylated hemoglobin hb alc by agarose gel
US6677158B2 (en) Method for measurement of glycated hemoglobin by a rapid strip test procedure
GB2118948A (en) Method for separation of hemoglobin a1c
JP6074369B2 (en) Solid support and method for increasing the recovery of biological material therefrom
JPS5861465A (en) Analytical method for blood
JP3285451B2 (en) Analysis method and analysis element for whole blood sample
US4476016A (en) Heart attack screening method, apparatus and kit for same
JP2021535380A (en) Microsampling detection in diabetes
Jeppsson et al. Genetic variants of alpha 1-antitrypsin and hemoglobin typed by isoelectric focusing in preselected narrow pH gradients with PhastSystem
JPS5892863A (en) Biochemical analysis method and its instrument and device
Steinberg et al. Clinical evaluation of Toxi· Prep™: a semiautomated solid-phase extraction system for screening of drugs in urine
CN112485453A (en) Liquid chromatography reagent for measuring glycosylated hemoglobin and preparation method thereof
US4338396A (en) Heart attack screening method and process
JPH0972904A (en) Dry test piece for measuring very small amount of hemoglobin a1c
EP3404418A2 (en) A diagnostic strip for determining the amount of sarcosine, creatinine and hydrogen peroxide in a biological or environmental sample
JPH0972905A (en) Dry tester for measuring very small amount of hemoglobin a1c
JPH08285850A (en) Dry test kit for blood specimen
EP1876450B1 (en) A method for processing whole blood for analyte determination